Waddell & Associates’s Elevance Health ELV Stock Holding History

Waddell & Associates’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$412K	Buy	1,065 +231	+28%	+$85.7K	0.02%	311
2026 Q1	$244K	Sell	834 -407	-33%	-$134K	0.01%	374
2025 Q4	$435K	Buy	1,241 +32	+3%	+$10.8K	0.03%	201
2025 Q3	$391K	Buy	1,209 +490	+68%	+$152K	0.03%	171
2025 Q2	$280K	Sell	719 -70	-9%	-$28.2K	0.03%	181
2025 Q1	$343K	Hold	789	–	–	0.04%	111
2024 Q4	$291K	Hold	789	–	–	0.03%	125
2024 Q3	$410K	Hold	789	–	–	0.05%	92
2024 Q2	$428K	Hold	789	–	–	0.06%	83
2024 Q1	$409K	Hold	789	–	–	0.06%	83
2023 Q4	$372K	Hold	789	–	–	0.05%	94
2023 Q3	$344K	Hold	789	–	–	0.05%	112
2023 Q2	$351K	Sell	789 -4	-0.5%	-$1.84K	0.05%	108
2023 Q1	$365K	Hold	793	–	–	0.06%	97
2022 Q4	$407K	Buy	793 +239	+43%	+$121K	0.07%	86
2022 Q3	$252K	Buy	+554	New	+$265K	0.05%	111
2022 Q2	–	Sell	-554	Closed	-$272K	–	146
2022 Q1	$272K	Hold	554	–	–	0.04%	106
2021 Q4	$257K	Hold	554	–	–	0.04%	105
2021 Q3	$207K	Hold	554	–	–	0.04%	108
2021 Q2	$212	Buy	+554	New	+$212K	0.03%	115

Other funds holding ELV

HGIM

High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MIHAS

Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Munich Reinsurance Munich $4.57B AUM 28.39% 1-Year Est. Return

Waddell & Associates's ELV Position: Q2 2026 in Review

Waddell & Associates increased its Elevance Health (ELV) stake by 28% in Q2 2026, buying an estimated $85.7K and bringing the position to 1,065 shares worth $412K. The position accounts for 0.02% of the portfolio, ranked #311.

Waddell & Associates first reported a position in ELV in Q2 2021 and has held it in 20 quarters since. The position peaked at $435K in Q4 2025. 487 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Waddell & Associates held 1,065 shares of Elevance Health worth $412K as of Q2 2026.
Waddell & Associates bought 231 Elevance Health shares in Q2 2026, an estimated $85.7K.
Elevance Health made up 0.02% of Waddell & Associates's portfolio in Q2 2026, its #311 holding.
Waddell & Associates first reported a position in Elevance Health in Q2 2021 and has held it in 20 quarters since.
Waddell & Associates's Elevance Health position peaked at $435K in Q4 2025.
487 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.